Zolpidem Tartrate Tablet, Extended Release
Product Images NDC 71205-286
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Zolpidem Tartrate (NDC 71205-286). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Im-2 (B0207b5f 53fa 4b2c 8608 4095874aff98 02)
This is a chart showing the plasma concentrations (in ng/mL) of zolpidem, a medication used to treat insomnia, over time. The chart compares the concentrations of extended-release tablets containing 12.5 mg of zolpidem tartrate versus immediate-release tablets containing 10 mg of zolpidem tartrate. The X-axis represents time in hours and the Y-axis represents the concentration in ng/mL. There are no readable values for the concentrations or time intervals due to the poor quality of the .*
71205-286-30 (B0207b5f 53fa 4b2c 8608 4095874aff98 04)
This is a description of a prescription medication containing Zolpidem Tartrate with a strength of 12.5mg. It is an extended-release medication dispensed in the form of 30 film-coated tablets. The product contains two layers, is blue colored, round, biconvex and has "E62" on one side and "LU" on the other side. The medication guide should be provided separately to each patient. This medication should be stored at 25°C (77°F) and kept out of the reach of children. The product is manufactured by Lupin Limited, Goa, India and packaged by Proficient Rx LP in Thousand Oaks, CA 91320. The product has a GTIN of 0371205286309 and a lot #0000.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.